Search

Steven Yatomi-Clarke

Steven Yatomi-Clarke has a strong track record of financing multiple private and public biotechnology companies. Mr Yatomi-Clarke holds more than 15 years’ experience in investment banking with a particular focus on the life sciences/biotechnology sector.
Bio last updated 03 Aug 2016

Positions - Current

PositionCompanyYearCompany's current rankWA staff
Chief Executive Officer, Managing DirectorPrescient Therapeutics2014

Directors Interests

CompanyDateTransaction typeNumber of sharesPrice per shareTransaction valueNature of change
Prescient Therapeutics30 Jun 2016Issued70,000$0.00Rights issue
Prescient Therapeutics30 Jun 2016Issued140,000$0.09$12,600Rights issue

Directors Shareholdings

CompanyDirect sharesIndirect sharesTotal sharesTotal value
Prescient Therapeutics4,394,4124,394,412$571,274

Latest Equity Capital Markets Deals

DateCompanyTransaction TypeTotal Value
18/05/16Prescient TherapeuticsPlacement$7.0m>>
30/06/16Prescient TherapeuticsEntitlement offer$3.4m>>

Roles

2014
Chief Executive Officer, Managing Director
Year started and most recent title

Share Transactions

14/06/13
$8k Bought
16/04/13
$9k Bought
Total value as at the date of the transaction
Source: Morningstar

BNiQ Disclaimer